OTC Volume Buzzers (ATTD, AMBS, ALZM, NSPR, ACTC) Is announcing Investment Highlights on Attitude Drinks (OTC: ATTD), Amarantus (OTC: AMBS), Allezoe Medical (OTC: ALZM), InspireMD (OTC: NSPR), Advanced Cell (OTC: ACTC)

New York, New York, October 5, 2012 -- Attitude Drinks Inc (NDA) (OTC: ATTD) augmented 10.0% to $0.0011 on a traded volume of 7.44 million shares. The 52-week range for the stock is $.00 and $0.01. The Company has Price/Sales ratio of 2.85. The Company deals on the non-alcoholic single serving beverage business, developing and marketing of milk based products in two segments: sports recovery and functional dairy.

Will ATTD Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here

AMARANTUS BIOSCIENCES INC (OTC: AMBS) slipped 29.41% to $0.0048 on a traded volume of 5.81 million shares. The Company announced the commitment by former Minnesota Vikings Pro Bowl linebacker E.J. Henderson to support the further development of Amarantus' TBI research collaboration with Banyan Biomarkers

Amarantus BioSciences Inc is a biotechnology company developing new treatments for brain-related disorders including Parkinson's disease and Traumatic Brain Injuries centered on its unique proprietary anti-apoptotic therapeutic protein known as MANF.

How Should Investors Trade AMBS After The Recent Momentum, Find Out Here

Allezoe Medical Holdings Inc (OTC: ALZM) decreased 4.55% to $0.0021 on a traded volume of 791k shares. The 52-week range for the stock is $0.00 and $0.09. The 50-Day Moving Average and 200-Day Moving Average prices is $0.00 and $0.01 respectively. The Company is focused on developing a portfolio of companies in the medical device, solutions and services sector.

Don’t Miss Any Updates on ALZM & Get Free News Alert In Your Inbox by Signing Up Here

InspireMD Inc (OTC: NSPR) went up 0.43% to $2.33 on a traded volume of 550k shares. Recently, the Company has filed a registration with the U.S. Securities and Exchange Commission relating to a proposed $40 million underwritten public offering of shares. The Company plans to grant to the underwriters a 30-day option to purchase up to an aggregate of 15 percent additional shares of common stock to cover over-allotments.

The Company said that Ofir Paz, co-founder, board member and Chief Executive Officer intends to resign as CEO as part of a planned transition to prepare the Company for formal commercialization of its proprietary MGuard Embolic Protection Stent platform technology for patients with Acute Myocardial Infraction.

Get Free Special Trend Analysis On NSPR Here

Advanced Cell Technology Inc (OTC: ACTC) moved down 1.79% to $0.0712 on a traded volume of 1.75 million shares. The Company has entered into a $35 million common stock purchase agreement with Lincoln Park Capital Fun, LLC. Lincoln Park Capital Fun LLC is a Chicago-based institutional investor. Lincoln Park Capital made an initial purchase of $800,000 in common stock from the Company at a purchase price of $0.08 per share.

Get Free Special Trend Analysis On ACTC Here


Brian Burr


1419 Westwood Blvd Los Angeles, CA